Boothbay Fund Management’s Chemomab Therapeutics CMMB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.4K | Hold |
6,547
| – | – | ﹤0.01% | 1181 |
|
|
2025
Q1 | $28.5K | Hold |
6,547
| – | – | ﹤0.01% | 1144 |
|
|
2024
Q4 | $47.4K | Sell |
6,547
-85
| -1% | -$615 | ﹤0.01% | 1198 |
|
|
2024
Q3 | $41.7K | Hold |
6,632
| – | – | ﹤0.01% | 1323 |
|
|
2024
Q2 | $24.2K | Hold |
6,632
| – | – | ﹤0.01% | 1283 |
|
|
2024
Q1 | $20.7K | Hold |
6,632
| – | – | ﹤0.01% | 1329 |
|
|
2023
Q4 | $13.5K | Hold |
6,632
| – | – | ﹤0.01% | 1426 |
|
|
2023
Q3 | $23.7K | Hold |
6,632
| – | – | ﹤0.01% | 1457 |
|
|
2023
Q2 | $34.9K | Hold |
6,632
| – | – | ﹤0.01% | 1468 |
|
|
2023
Q1 | $42.2K | Sell |
6,632
-6,270
| -49% | -$39.9K | ﹤0.01% | 1780 |
|
|
2022
Q4 | $165K | Buy |
12,902
+3,559
| +38% | +$45.6K | ﹤0.01% | 1425 |
|
|
2022
Q3 | $93K | Sell |
9,343
-982
| -10% | -$9.78K | ﹤0.01% | 1772 |
|
|
2022
Q2 | $153K | Hold |
10,325
| – | – | ﹤0.01% | 1604 |
|
|
2022
Q1 | $198K | Buy |
10,325
+3,162
| +44% | +$60.6K | ﹤0.01% | 1502 |
|
|
2021
Q4 | $198K | Sell |
7,163
-3,702
| -34% | -$102K | ﹤0.01% | 1330 |
|
|
2021
Q3 | $482K | Sell |
10,865
-2,817
| -21% | -$125K | 0.01% | 910 |
|
|
2021
Q2 | $1.04M | Sell |
13,682
-1,758
| -11% | -$134K | 0.03% | 569 |
|
|
2021
Q1 | $1.77M | Buy |
+15,440
| New | +$1.77M | 0.07% | 282 |
|